- Home
- FROG vs PEN Comparison
FROG vs PEN Comparison
Compare FROG & PEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | FROG | PEN |
|---|---|---|
| Founded | 2008 | 2004 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Computer Software: Prepackaged Software | Medical/Dental Instruments |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 11.6B | 12.6B |
| IPO Year | 2020 | 2015 |
Fundamental Metrics
Financial Performance| Metric | FROG | PEN |
|---|---|---|
| Price | $102.07 | $319.13 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 23 | 16 |
| Target Price | $112.00 | ★ $361.58 |
| AVG Volume (30 Days) | ★ 1.4M | 339.2K |
| Earning Date | 11-05-2026 | 11-04-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | 1.59 | ★ 1155.56 |
| EPS | N/A | ★ 1.70 |
| Revenue | $531,840,000.00 | ★ $1,403,665,000.00 |
| Revenue This Year | $22.35 | $13.48 |
| Revenue Next Year | $17.94 | $12.98 |
| P/E Ratio | ★ N/A | $186.78 |
| Revenue Growth | ★ 24.12 | 17.50 |
| 52 Week Low | $34.05 | $221.26 |
| 52 Week High | $105.76 | $362.41 |
Technical Indicators
Market Signals| Indicator | FROG | PEN |
|---|---|---|
| Relative Strength Index (RSI) | 63.16 | 50.93 |
| Support Level | $84.25 | $315.42 |
| Resistance Level | $105.76 | $320.08 |
| Average True Range (ATR) | 4.22 | 1.59 |
| MACD | 0.74 | 0.15 |
| Stochastic Oscillator | 99.19 | 79.90 |
Price Performance
Historical ComparisonAbout FROG JFrog Ltd.
JFrog Ltd provides an end-to-end, hybrid, universal DevOps Platform that powers and controls the software supply chain, enabling organizations to continuously and securely deliver software updates across any system. Its product portfolio includes JFrog Artifactory; JFrog Pipelines; JFrog Xray; JFrog Distribution; JFrog Artifactory Edge; JFrog Mission Control and JFrog Insight. Geographically, it derives a majority of revenue from united states and also has its presence in Israel, India and other regions.
About PEN Penumbra Inc.
Domiciled in the US, Penumbra designs, manufactures, and markets an array of thrombectomy and embolization devices and equipment to mechanically remove blood clots. The firm sells mainly to hospitals and physicians. These minimally invasive devices are primarily used in the acute care setting for patients with stroke, pulmonary embolism, deep vein thrombosis, cranial aneurysms, and other vascular diseases.